Genmab — April 2017
-
Japan godkendelse kan komme i midten af året
-
Desuden er det ret svært at forudsige uptake i 2 linie vil jeg mene, men det positive er dog at der er flere patienter at tage af og responsraten og duration er markant bedre end i 4 linie. Jeg har selv sat 1,5 milliarder dollars for lang tid siden og mener at der er rimelig chance for at vi kommer højere hvis alle godkendelser går igennem
-
@Sukkeralf. Du plejer ellers at være meget konservativ
-
Tak Darvin. Så holdt Sydbanks konklusion, hvilket jeg var i tvivl om. Og ganske pæn stigning til trods for flere hverdage.
-
måned over måned?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind